Published Date: 14 Mar 2023
The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.
Read Full NewsOcular motor cranial neuropathy is associated with an increased risk for Parkinson’s disease, a new study shows.
Traumatic brain injury is bidirectionally associated with the incidence of stroke, dementia, epilepsy, and Parkinson’s disease, a retrospective study shows.
A large database study found overall 5- and 10-year improvement in pediatric cancer survival, but some cancers lag others, and demographic factors seem to influence trends.
Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.
A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.
All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.
Emerging evidence suggests coffee influences gut microbiota through bioactive compounds beyond caffeine, with potential effects on digestive and metabolic health.
1.
I Was Told I Had 6 Months to Live. That Was 20 Years Ago.
2.
Which Salvage Therapy Is Best for Recurrent Prostate Cancer?
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Chemoimmunotherapy Boosts Head and Neck Cancer Response
5.
Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.
1.
Essential Developments in Oncology for Healthcare Excellence
2.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
3.
Understanding Apoplexy: Symptoms, Causes, and Treatment Options
4.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
5.
Understanding the Rare Disease: Werner Syndrome Explained
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Navigating the Complexities of Ph Negative ALL - Part XIII
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation